The new T cells could help clinicians avoid the relapses that can occur in patients whose lymphoma cells lose CD19 - a prominent roadblock in standard CAR T cell therapy for B cell malignancies.
from Medindia Health News https://ift.tt/2lB62Mw
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
September 27, 2019
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.